PJ, June 2023, Vol 310, No 7974

ADHD and central nervous system stimulant prescribing nearly doubles in adults in three years

Exclusive: Prescribing of central nervous system stimulants and medicines for attention-deficit hyperactivity disorder in adults in England increased by 91% between January 2020 and January 2023.…

Case-based learning: insect bites and stings

How to identify and manage insect bites and stings, as well as prevention methods.…

Government to open five regional aseptic pharmacy ‘pathfinder’ hubs by 2027

The move to centralise aseptic medicine production in England has been welcomed, but there are calls for the government to commit to funding to allow for delivery.…

Monoclonal antibody found to improve COPD outcomes, trial results suggest

The monoclonal antibody treatment dupilumab was found to reduce the annual rate of moderate or severe exacerbations of chronic obstructive pulmonary disease when compared with placebo.…

NICE recommends new chronic heart failure treatment following discussions with manufacturer

Data suggest that up to 150,000 people in England would be eligible for treatment with dapagliflozin.…

Discharge medicines service has prevented almost 22,000 hospital readmissions, government says

The Department of Health and Social Care says community pharmacy has claimed for 216,700 patient referrals from hospital through the 'Discharge medicines service'.…

Bacterial vaginosis: diagnosis and management

Pharmacists can identify bacterial vaginosis and recommend appropriate treatment options to patients.…

NHS Education for Scotland creates three roles to boost advanced pharmacist practitioners

The programme leads will be tasked with helping health boards plan and implement advanced practice pilots, while working to increase the number of designated prescribing practitioners across community pharmacy.…

Weight loss drug semaglutide added to list of medicines that cannot be exported or ‘hoarded’

The list contains products that meet the needs of UK patients but may contribute to medicines shortages if they were exported.…

Beyond RCTs: the real-world evidence revolution

Enthusiasm is growing for the use of real-world evidence as a basis for regulatory and clinical decisions. However, not everyone believes this type of data is suitable, with some experts calling for the conduct of randomised controlled trials to be made easier instead.…